title: Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
authors.affiliation: Center for Biomedical Ethics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
authors.forename: S G
authors.initials: SG
authors.lastname: Post
authors.forename: B
authors.initials: B
authors.lastname: Beerman
authors.forename: H
authors.initials: H
authors.lastname: Brodaty
authors.forename: A W
authors.initials: AW
authors.lastname: Gaines
authors.forename: S G
authors.initials: SG
authors.lastname: Gauthier
authors.forename: D S
authors.initials: DS
authors.lastname: Geldmacher
authors.forename: S
authors.initials: S
authors.lastname: Hill
authors.forename: A
authors.initials: A
authors.lastname: Homma
authors.forename: M N
authors.initials: MN
authors.lastname: Rossor
authors.forename: P J
authors.initials: PJ
authors.lastname: Whitehouse
authors.forename: B
authors.initials: B
authors.lastname: Winblad
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003431:Cross-Cultural Comparison; D003704:Dementia / Q000188:drug therapy*; D004339:Drug Compounding; D004994:Ethics, Pharmacy; D015577:Geriatric Assessment; D006801:Humans; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
chemical_list: D018697:Nootropic Agents